In patients with these mutations, targeted therapies like erlotinib (Tarceva ... Despite these challenges, the opportunities are vast as the future of cancer care lies in the continued evolution of ...

Cancer evolution and progression is a complex process that involves the transformation of normal cells into malignant ones, leading to the development of tumors and their potential spread ...

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...

Millions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic myeloid leukemia (CML), advancements in treatment selection could ...

Figure 1. The frequency and distribution of cancer susceptibility genes (CSGs) with more than one pathogenic/likely pathogenic germline mutation detected in patients with esophageal squamous cell ...

Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...

A major breakthrough in cancer genetics has been achieved, paving the way for more effective prevention, early detection, and treatment strategies for patients with BRCA2 mutations.

1Department of Oncology, University of Oxford, Oxford, United Kingdom. *Corresponding Author: Connor E. Woolley, Department of Oncology, University of Oxford, Old Road Campus Research Building, ...

Get Instant Summarized Text (Gist) A gene mutation in PIK3CA has been linked to immune system signaling in canine hemangiosarcoma, an aggressive cancer forming malignant blood vessels. This ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.